目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global hospital infection therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global hospital infection therapeutics market 2017 - 2021 ($ million)
4.2 Drug Class Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Drug Class Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Drug Class
6.1 Market segments
Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
6.2 Comparison by Drug Class
Exhibit 32: Chart on Comparison by Drug Class
Exhibit 33: Data Table on Comparison by Drug Class
6.3 Antibiotics drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
6.4 Antifungal drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Antifungal drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Antifungal drugs - Year-over-year growth 2022-2027 (%)
6.5 Antiviral drugs - Market size and forecast 2022-2027
Exhibit 42: Chart on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Antiviral drugs - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Antiviral drugs - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Drug Class
Exhibit 46: Market opportunity by Drug Class ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 47: Chart on Type - Market share 2022-2027 (%)
Exhibit 48: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 49: Chart on Comparison by Type
Exhibit 50: Data Table on Comparison by Type
7.3 Respiratory tract infections - Market size and forecast 2022-2027
Exhibit 51: Chart on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
7.4 Surgical site infections - Market size and forecast 2022-2027
Exhibit 55: Chart on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Surgical site infections - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Surgical site infections - Year-over-year growth 2022-2027 (%)
7.5 Bloodstream infections - Market size and forecast 2022-2027
Exhibit 59: Chart on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Bloodstream infections - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Bloodstream infections - Year-over-year growth 2022-2027 (%)
7.6 Gastrointestinal infections - Market size and forecast 2022-2027
Exhibit 63: Chart on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
7.7 Urinary tract infections - Market size and forecast 2022-2027
Exhibit 67: Chart on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Urinary tract infections - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Urinary tract infections - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Type
Exhibit 71: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 73: Chart on Market share by geography 2022-2027 (%)
Exhibit 74: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 75: Chart on Geographic comparison
Exhibit 76: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 105: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 109: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 111: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 112: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 113: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 114: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 116: Overview on factors of disruption
11.4 Industry risks
Exhibit 117: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 118: Vendors covered
12.2 Market positioning of vendors
Exhibit 119: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 120: Abbott Laboratories - Overview
Exhibit 121: Abbott Laboratories - Business segments
Exhibit 122: Abbott Laboratories - Key news
Exhibit 123: Abbott Laboratories - Key offerings
Exhibit 124: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 125: AbbVie Inc. - Overview
Exhibit 126: AbbVie Inc. - Product / Service
Exhibit 127: AbbVie Inc. - Key news
Exhibit 128: AbbVie Inc. - Key offerings
12.5 Achilles Therapeutics plc
Exhibit 129: Achilles Therapeutics plc - Overview
Exhibit 130: Achilles Therapeutics plc - Product / Service
Exhibit 131: Achilles Therapeutics plc - Key offerings
12.6 AstraZeneca Plc
Exhibit 132: AstraZeneca Plc - Overview
Exhibit 133: AstraZeneca Plc - Product / Service
Exhibit 134: AstraZeneca Plc - Key news
Exhibit 135: AstraZeneca Plc - Key offerings
12.7 Bayer AG
Exhibit 136: Bayer AG - Overview
Exhibit 137: Bayer AG - Business segments
Exhibit 138: Bayer AG - Key news
Exhibit 139: Bayer AG - Key offerings
Exhibit 140: Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 141: Bristol Myers Squibb Co. - Overview
Exhibit 142: Bristol Myers Squibb Co. - Product / Service
Exhibit 143: Bristol Myers Squibb Co. - Key news
Exhibit 144: Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Exhibit 150: Gilead Sciences Inc. - Overview
Exhibit 151: Gilead Sciences Inc. - Product / Service
Exhibit 152: Gilead Sciences Inc. - Key news
Exhibit 153: Gilead Sciences Inc. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 154: GlaxoSmithKline Plc - Overview
Exhibit 155: GlaxoSmithKline Plc - Business segments
Exhibit 156: GlaxoSmithKline Plc - Key offerings
Exhibit 157: GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson
Exhibit 158: Johnson and Johnson - Overview
Exhibit 159: Johnson and Johnson - Business segments
Exhibit 160: Johnson and Johnson - Key news
Exhibit 161: Johnson and Johnson - Key offerings
Exhibit 162: Johnson and Johnson - Segment focus
12.13 Merck and Co. Inc.
Exhibit 163: Merck and Co. Inc. - Overview
Exhibit 164: Merck and Co. Inc. - Business segments
Exhibit 165: Merck and Co. Inc. - Key news
Exhibit 166: Merck and Co. Inc. - Key offerings
Exhibit 167: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 168: Novartis AG - Overview
Exhibit 169: Novartis AG - Business segments
Exhibit 170: Novartis AG - Key offerings
Exhibit 171: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 172: Pfizer Inc. - Overview
Exhibit 173: Pfizer Inc. - Product / Service
Exhibit 174: Pfizer Inc. - Key news
Exhibit 175: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 176: Sanofi SA - Overview
Exhibit 177: Sanofi SA - Business segments
Exhibit 178: Sanofi SA - Key news
Exhibit 179: Sanofi SA - Key offerings
Exhibit 180: Sanofi SA - Segment focus
12.17 Viatris Inc.
Exhibit 181: Viatris Inc. - Overview
Exhibit 182: Viatris Inc. - Business segments
Exhibit 183: Viatris Inc. - Key offerings
Exhibit 184: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global hospital infection therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Drug Class Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits31: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Antifungal drugs - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Antifungal drugs - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Antiviral drugs - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Antiviral drugs - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Drug Class ($ million)
Exhibits47: Chart on Type - Market share 2022-2027 (%)
Exhibits48: Data Table on Type - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Type
Exhibits50: Data Table on Comparison by Type
Exhibits51: Chart on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Surgical site infections - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Surgical site infections - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Bloodstream infections - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Bloodstream infections - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Urinary tract infections - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Urinary tract infections - Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Type ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share by geography 2022-2027 (%)
Exhibits74: Data Table on Market share by geography 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity by geography ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Abbott Laboratories - Overview
Exhibits121: Abbott Laboratories - Business segments
Exhibits122: Abbott Laboratories - Key news
Exhibits123: Abbott Laboratories - Key offerings
Exhibits124: Abbott Laboratories - Segment focus
Exhibits125: AbbVie Inc. - Overview
Exhibits126: AbbVie Inc. - Product / Service
Exhibits127: AbbVie Inc. - Key news
Exhibits128: AbbVie Inc. - Key offerings
Exhibits129: Achilles Therapeutics plc - Overview
Exhibits130: Achilles Therapeutics plc - Product / Service
Exhibits131: Achilles Therapeutics plc - Key offerings
Exhibits132: AstraZeneca Plc - Overview
Exhibits133: AstraZeneca Plc - Product / Service
Exhibits134: AstraZeneca Plc - Key news
Exhibits135: AstraZeneca Plc - Key offerings
Exhibits136: Bayer AG - Overview
Exhibits137: Bayer AG - Business segments
Exhibits138: Bayer AG - Key news
Exhibits139: Bayer AG - Key offerings
Exhibits140: Bayer AG - Segment focus
Exhibits141: Bristol Myers Squibb Co. - Overview
Exhibits142: Bristol Myers Squibb Co. - Product / Service
Exhibits143: Bristol Myers Squibb Co. - Key news
Exhibits144: Bristol Myers Squibb Co. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: Gilead Sciences Inc. - Overview
Exhibits151: Gilead Sciences Inc. - Product / Service
Exhibits152: Gilead Sciences Inc. - Key news
Exhibits153: Gilead Sciences Inc. - Key offerings
Exhibits154: GlaxoSmithKline Plc - Overview
Exhibits155: GlaxoSmithKline Plc - Business segments
Exhibits156: GlaxoSmithKline Plc - Key offerings
Exhibits157: GlaxoSmithKline Plc - Segment focus
Exhibits158: Johnson and Johnson - Overview
Exhibits159: Johnson and Johnson - Business segments
Exhibits160: Johnson and Johnson - Key news
Exhibits161: Johnson and Johnson - Key offerings
Exhibits162: Johnson and Johnson - Segment focus
Exhibits163: Merck and Co. Inc. - Overview
Exhibits164: Merck and Co. Inc. - Business segments
Exhibits165: Merck and Co. Inc. - Key news
Exhibits166: Merck and Co. Inc. - Key offerings
Exhibits167: Merck and Co. Inc. - Segment focus
Exhibits168: Novartis AG - Overview
Exhibits169: Novartis AG - Business segments
Exhibits170: Novartis AG - Key offerings
Exhibits171: Novartis AG - Segment focus
Exhibits172: Pfizer Inc. - Overview
Exhibits173: Pfizer Inc. - Product / Service
Exhibits174: Pfizer Inc. - Key news
Exhibits175: Pfizer Inc. - Key offerings
Exhibits176: Sanofi SA - Overview
Exhibits177: Sanofi SA - Business segments
Exhibits178: Sanofi SA - Key news
Exhibits179: Sanofi SA - Key offerings
Exhibits180: Sanofi SA - Segment focus
Exhibits181: Viatris Inc. - Overview
Exhibits182: Viatris Inc. - Business segments
Exhibits183: Viatris Inc. - Key offerings
Exhibits184: Viatris Inc. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations